SHIELD HD

Active, not recruiting

mise à jour

Cette étude de deux ans sur l’histoire naturelle des HDGECs, sponsorisée par Triplet Therapeutics, recueille des informations longitudinales liées à l’instabilité somatique et aux gènes de réponse aux dommages de l’ADN, ainsi que des évaluations établies de la progression de la maladie. L’étude a recruté 70 participants à ce jour, et des évaluations de suivi sont en cours sur des sites en Amérique du Nord et en Europe. Les résultats serviront de base aux évaluations préalables à un futur essai thérapeutique.

À PROPOS

SPONSOR

Triplet Therapeutics, Inc.

PARTICIPANTS

70

SHIELD HD est une étude internationale qui suivra dans le temps un groupe de personnes atteintes ou susceptibles d’être atteintes de la maladie de Huntington. SHIELD HD recueillera des informations sur la santé, notamment les antécédents médicaux et des échantillons de sang et de liquide céphalorachidien. Les participants subiront également des IRM et des tests de fonctions cognitives et motrices. Ces informations seront utilisées pour évaluer l’histoire naturelle de la MH et ses biomarqueurs associés à la modulation du nombre de répétitions CAG (cytosine-adénine-guanine) dans le gène mutant de la Huntingtine (HTT). Les résultats de cette étude serviront de base à l’évaluation d’un futur essai de traitement interventionnel.

Cette étude internationale suivra un groupe de personnes qui ont ou risquent d’avoir une MH. Des informations sur la santé seront recueillies, notamment les antécédents médicaux et des échantillons de sang et de LCR. Les participants subiront également des IRM et des tests de fonction cognitive et motrice. Ces informations seront utilisées pour étudier l’histoire naturelle de la MH et les biomarqueurs qui sont liés aux changements dans la répétition de l’ACG.

Date estimée de fin de l’étude : Décembre 2022

Ages éligibles
pour l'étude:

18 ans et plus

(Adulte, Adulte âgé)

Sexes éligibles
pour l'étude:

Tous

Accepte les volontaires en bonne santé:

Non

Critères d'inclusion

  • Capacité à comprendre les objectifs et les procédures de l’étude.
  • Documentation de la maladie génétiquement confirmée par un test ADN direct, définie comme une longueur de répétition CAG ≥39 dans le gène HTT.
  • Capacité à subir et à tolérer des examens IRM.
  • Capacité à tolérer les prises de sang et les ponctions lombaires.

Critères d'exclusion

  • Toute condition, y compris la chorée sévère et la démence, qui empêcherait d’écrire ou d’effectuer des tâches à l’aide d’un stylo ou d’un papier, d’une tablette ou d’un ordinateur, tel que déterminé par l’investigateur.
  • Traitement avec un médicament expérimental dans les 30 jours précédant la sélection ou dans les 5 demi-vies du médicament expérimental, selon la période la plus longue.
  • Antécédents de thérapie génique, de transplantation cellulaire ou de toute autre chirurgie expérimentale du cerveau.

PAYS

COUNTRIES

FRANCE

TRIAL SITE:
ICM – Institut du Cerveau et de la Moelle épinière

Address: Paris, France, 75013

Active, Not Recruiting

GERMANY

TRIAL SITE:
George-Huntington-Institut 

Address: Münster, Germany, 48149.

Active, Not Recruiting

UNITED KINGDOM

TRIAL SITE:
University College London – Institute of Neurology & The National Hospital for Neurology and Neurosurgery

Address: London, United Kingdom

Active, Not Recruiting

new FB feed (19)

dictionary:

SNP-single nucleotide polymorphisms

a single-letter spelling difference in a gene. SNPs, pronounced ‘snips’, are common and most don’t change the function of the gene.

 
new FB feed (19)

dictionary:

at risk

You do not know if you carry the genetic mutation for HD gene 

 
new FB feed (19)

dictionary:

TFC-total functional capacity

A standardized rating scale for function in HD, used to assess capacity to work, handle finances, perform domestic chores and self-care tasks.
Scores range from 0 to 13, with higher scores indicating better functional capacity. 

 
new FB feed (19)

dictionary:

Double-blinded

 means that neither the participant nor the clinical trial doctor can choose or know the group the participant is in until the trial is over. This approach helps to prevent bias.

new FB feed (19)

dictionary:

Open label

A trial in which the patient and doctor know what drug is being used. Open label trials are susceptible to bias through placebo effects.

new FB feed (19)

dictionary:

Gene therapy

a technique that aims to treat or prevent diseases by modifying a person’s genes. It involves introducing, removing, or changing genetic material (DNA or RNA) within a patient’s cells.

new FB feed (19)

dictionary:

UHDRS- Unified Huntington Disease Rating Scale

A standardized neurological examination that aims to provide a uniform assessment of the clinical features of HD

new FB feed (19)

dictionary:

CAG repeat

The stretch of DNA at the beginning of the HD gene, which contains the sequence CAG repeated many times, and is abnormally long in people who will develop HD

new FB feed (19)

dictionary:

Wild-type

the opposite of ‘mutant’. Wild-type huntingtin, for example, is the ‘normal’, ‘healthy’ protein

new FB feed (19)

dictionary:

Tolerabilty

How well a person can handle a treatment without having serious or uncomfortable side effects.

new FB feed (19)

dictionary:

Striatum

Part of the brain that  coordinates multiple aspects of cognition, including both motor and action planning, decision-making, motivation, reinforcement, and reward system.

new FB feed (19)

dictionary:

Randomized allocation

A type of allocation strategy in which participants are assigned to the arms of a clinical trial by chance.

new FB feed (19)

dictionary:

Radioligand

a radioactive substance that binds to a specific target in the body, allowing visualization of that target’s distribution and activity

new FB feed (19)

dictionary:

Protein

Protein builds, maintains, and replaces the tissues in your body. The building blocks of life.

new FB feed (19)

dictionary:

Premanifest / Prodromal

Prior to onset or diagnosis of movement symptoms.

new FB feed (19)

dictionary:

Placebo

A placebo is a dummy medicine containing no active ingredients. The placebo effect is a psychological effect that causes people to feel better even if they’re taking a pill that doesn’t work.

new FB feed (19)

dictionary:

PK - Pharmacokinetics

The movement of drugs through the body

new FB feed (19)

dictionary:

PD - Pharmacodynamics

The body’s biological response to drugs

new FB feed (19)

dictionary:

PET scan

Positron emission tomography which produces detailed 3-dimensional images of the inside of the body.

new FB feed (19)

dictionary:

Neuron

Brain cells that store and transmit information

new FB feed (19)

dictionary:

MRI

Magentic resonance imaging: A technique using powerful magnetic fields to produce detailed images and visualizes the structure of organs, tissues, and bones 

new FB feed (19)

dictionary:

mHTT

Mutant huntingtin protein. The protein produced by the faulty HD gene.

new FB feed (19)

dictionary:

Manifest

after HD diagnosis, or when symptoms are already showing

new FB feed (19)

dictionary:

Longitudinal study

A study where each participant is looked at several times over a time period – unlike a cross-sectional study, where each participant is looked at only once

new FB feed (19)

dictionary:

HTT

one abbreviation for the gene that causes Huntington’s disease. The same gene is also called HD and IT-15

new FB feed (19)

dictionary:

fMRI

functional MRI:As with MRI, a technique using powerful magnetic fields  but focusing on brain function by measuring and mapping changes in blood flow, revealing which areas of the brain are active during specific tasks or cognitive processes

new FB feed (19)

dictionary:

CSF - cerebrospinal fluid

A clear fluid produced by the brain, which surrounds and supports the brain and spinal cord.

new FB feed (19)

dictionary:

Efficacy

A measure of whether a treatment works or not

new FB feed (19)

dictionary:

ASO(Antisense oligonucleotides)

A type of gene silencing treatment in which specially designed DNA molecules are used to switch off a gene

new FB feed (19)

dictionary:

Biomarker

a test of any kind – including blood tests, thinking tests and brain scans – that can measure or predict the progression of a disease like HD. Biomarkers may make clinical trials of new drugs quicker and more reliable

new FB feed (19)

dictionary:

BDNF

Brain-derived neurotrophic factor: a growth factor that may be able to protect neurons in HD.

new FB feed (19)

dictionary:

Allele

one of the two copies of a gene

new FB feed (19)

dictionary:

Plasma

Liquid component of the blood.

new FB feed (19)

dictionary:

Gene

The basic unit of heredity passed from parent to child. Genes are made up of sequences of DNA and are arranged, one after another, at specific locations on chromosomes in the nucleus of cells.

new FB feed (19)

dictionary:

Phase

Clinical trial phases are different stages of research that assess the safety and effectiveness of a new medical treatment or intervention in humans.

Each phase has a specific goal and involves a different number of participants. Generally, there are 4 phases (I-IV), with Phase I focusing on safety and dosage, Phase II on efficacy and side effects, Phase III on comparing the new treatment with standard treatments, and Phase IV on long-term safety monitoring.